Jin-Sung Chung   Vijay Ramani   Masato Kobayashi   Farjana Fattah   Vinita Popat   Song Zhang   Ponciano D Cruz Jr   David E Gerber   Kiyoshi Ariizumi   
Clinical cancer research : an official journal of the American Association for Cancer Research 26(6) 1449-1459 2020年3月 [査読有り]
PURPOSE: Immune checkpoint inhibitors (ICI) benefit only a minority of treated patients with cancer. Identification of biomarkers distinguishing responders and nonresponders will improve management of patients with cancer. Because the DC-HIL check...